-
Mashup Score: 3
The FDA today published more than 200 decision letters, known as complete response letters (CRLs).
Source: www.fda.govCategories: General Medicine NewsTweet
-
Mashup Score: 3
CARTITUDE-1 evaluated ciltacabtagene autoleucel (cilta-cel) in patients with heavily pretreated relapsed/refractory multiple myeloma (RRMM). We describe overall survival (OS), ≥5-year progression-free outcomes, associated biomarkers, and safety, with a …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
DOI: https://t.co/84AQoldiln
-
-
Mashup Score: 65Global Access to Multiple Myeloma Therapies | JCO Global Oncology - 1 month(s) ago
PURPOSEInitial reports indicate that access to contemporary therapies currently used in North America for the treatment of multiple myeloma (MM) varies internationally. No studies have quantitatively reported the extent of disparities in the access to MM …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
Global Access to Multiple Myeloma Therapies by @Rawana_97 & GLAMM team @JCOGO_ASCO @USMIRCNEWS @OncoAlert @Larvol #USMIRC #mmsm #MedTwitter #MedEd #سرطان_الدم #المايلوما https://t.co/HQo5iPYRco https://t.co/UfvAXAIMPB
-
-
Mashup Score: 3
CARTITUDE-1 evaluated ciltacabtagene autoleucel (cilta-cel) in patients with heavily pretreated relapsed/refractory multiple myeloma (RRMM). We describe overall survival (OS), ≥5-year progression-free outcomes, associated biomarkers, and safety, with a …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
DOI: https://t.co/84AQoldiln
-
-
Mashup Score: 6Global Access to Multiple Myeloma Therapies | JCO Global Oncology - 1 month(s) ago
PURPOSEInitial reports indicate that access to contemporary therapies currently used in North America for the treatment of multiple myeloma (MM) varies internationally. No studies have quantitatively reported the extent of disparities in the access to MM …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
3/ ♻️While there is potential for a cure in relapsed myeloma, access to CAR-T therapy remains a significant challenge. Not all treatment centers in the US or abroad have access to this therapy, which presents additional obstacles. - GLAMM study https://t.co/HZdDRPqVll - in
-
-
Mashup Score: 65Global Access to Multiple Myeloma Therapies | JCO Global Oncology - 1 month(s) ago
PURPOSEInitial reports indicate that access to contemporary therapies currently used in North America for the treatment of multiple myeloma (MM) varies internationally. No studies have quantitatively reported the extent of disparities in the access to MM …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
Global Access to Multiple Myeloma Therapies by @Rawana_97 & GLAMM team @JCOGO_ASCO @USMIRCNEWS @OncoAlert @Larvol #USMIRC #mmsm #MedTwitter #MedEd #سرطان_الدم #المايلوما https://t.co/HQo5iPYRco https://t.co/UfvAXAIMPB
-
-
Mashup Score: 7Myeloma | LARVOL Onco Data Podcast with Dr. Al-Ola Abdallah - 1 month(s) ago
In this episode, Dr. Al-Ola Abdallah discusses the GLAMM study on Myeloma treatment access. He shares insights into the barriers to treatment, particularly i…
Source: www.youtube.comCategories: General Medicine NewsTweet-
https://t.co/VET9yNqwYJ
-
-
Mashup Score: 57Global Access to Multiple Myeloma Therapies | JCO Global Oncology - 1 month(s) ago
PURPOSEInitial reports indicate that access to contemporary therapies currently used in North America for the treatment of multiple myeloma (MM) varies internationally. No studies have quantitatively reported the extent of disparities in the access to MM …
Source: ascopubs.orgCategories: General Medicine NewsTweet-
Global Access to Multiple Myeloma Therapies by @Rawana_97 & GLAMM team @JCOGO_ASCO @USMIRCNEWS @OncoAlert @Larvol #USMIRC #mmsm #MedTwitter #MedEd #سرطان_الدم #المايلوما https://t.co/HQo5iPYRco https://t.co/UfvAXAIMPB
-
-
Mashup Score: 27Acute Kidney Injury in Patients with Cancer | NEJM - 2 month(s) ago
Review Article from The New England Journal of Medicine — Acute Kidney Injury in Patients with Cancer
Source: www.nejm.orgCategories: General Medicine NewsTweet-
Acute Kidney Injury in Patients with PCD #mmsm #myeloma #USMIRC #MedTwitter #MedEd @OncoAlert https://t.co/rxSkfUPZxb https://t.co/IHhJorhmUd
-
-
Mashup Score: 14Bortezomib to Treat the TEMPI Syndrome | NEJM - 2 month(s) ago
Telangiectasias, erythrocytosis, monoclonal gammopathy, perinephric-fluid collection, and intrapulmonary shunting are characteristic of the TEMPI syndrome. A case report documents improvement with …
Source: www.nejm.orgCategories: General Medicine NewsTweet-
Bortezomib to treat The TEMPI syndrome https://t.co/mB6Egfbru2 #mmsm #myeloma #MedEd @OncoAlert @USMIRCNEWS #USMIRC #سرطان_الدم #المايلوما https://t.co/pTFbnvFUnU
-
https://t.co/YNl33n2cp4